188例女性不孕症病因及预后的临床研究

目的 研究女性不孕症病因及预后。方法 采用 WHO女性不孕检查和诊断标准,对91例女性原发不孕症和97例女性继发不孕症进行临床检查、病因诊断及预后分析。结果 188例女性不孕症中共诊断出225种病因,其中81.38％为单一因素,18.62％为复合因素;内分泌因素和输卵管因素分别占45.33％和36.01％,前者在女性原发不孕症中占55.76％,其中92.16％系性腺轴功能失调,后者在女性继发不孕症中占50.41％,两组间有显著差异(P<0.01)。在对病因治疗后妊娠的64例病人中,内分泌因素占71.88％;FTR治疗输卵管阻塞的成功率在继发不孕症组显著高于原发不孕症组(P<0.01)。结论 内分泌因素和输卵管因素是女性不孕的主要原因,前者在女性原发不孕症中占首位,后者在女性继发不孕症中占首位。促排卵是治疗女性不孕症的关键,FTR是一种非手术治疗近端输卵管阻塞的有效方法。

Clinical Study of the Pathogeny and the Prognosis in 188 Cases of Female Sterility

Objective To study the pathogeny and the prognosis of female sterility. Methods Examined and diagnosed 91 cases female primary sterility and 97 cases female secondary sterility according to the WHo standarol for diagnosis and examination. Results There were 225 pathogenies in 188 cases,among them 81. 38% were single factor and 18. 62% were clomplex factors. The factors of endocrinology and oviduct were 45- 33% and 36. 01% ,respectively. In the female primary sterility,the factor of endocrinology was 55. 76%. In the female secondary sterility,the factor of oviduct was 50.41%.The difference was remarkable between the both groups (P<0. 01) . Among the 64 cases pregnacy by treated, the factor of endocrinology was 71.88%. In oviduct block cases,the success rate in the secondary sterility group was singnificantly higher than in the primary sterility group(P<0.01)treated by FTR.Conclusion The factor of endocrinology and oviduct were improtent factors in female sterility. The factor of the endocrinology was the fast factor in the female primary sterility. The factor of the oviduct was the fast factor too,in the female secondary sterility. The ovlution induction was the key to treated female sterility. FTR was an effective method for treating the near oviduct block.